A Study Comparing ex Vivo MRI Versus Radiography of Breast Specimens

NCT ID: NCT01869335

Last Updated: 2013-06-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

260 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-05-31

Study Completion Date

2015-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Radiography of breast specimens is currently the only radiological procedure used to verify removal of microcalcifications and presence of tumor-free margins after breast surgical resection. Ex vivo MRI will be tested for its ability to detect residual tumor tissue not detected by radiography in resected breast tumor specimens and/or its ability to verify tumor-free margins in breast cancer detected by MRI only.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

radiography

Arm1: patients undergo mammographic localizations and radiography of the specimen after surgical resection.

Group Type ACTIVE_COMPARATOR

radiography

Intervention Type DEVICE

MRI (magnetic resonance imaging)

Arm2: patients undergo MRI localization and ex vivo MRI after surgical resection.

Group Type ACTIVE_COMPARATOR

MRI (magnetic resonance imaging)

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

radiography

Intervention Type DEVICE

MRI (magnetic resonance imaging)

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women with malignant breast disease identified by microcalcifications without clinically evident disease
* Women candidate to breast preserving surgery

Exclusion Criteria

* Cardiac pacemaker, defibrillators, cardiac monitors
* Brain stimulators, implantable spinal stimulators
* Vascular and aneurismal clips
* Hemostatic clips
* Infusion pumps
* Glaucoma drainage implants
* Metallic foreign body positioned in vital organ of the patients
* Some heart valves
* Some vascular access ports, infusion pumps and catheters
* Permanent contraceptive tubal device
* Kidney disease
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Roberto Agresti, MD

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fondazione IRCCS Istituto Nazionale dei Tumori

Milan, , Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Roberto Agresti, MD

Role: CONTACT

+39 02 2390 ext. 2168

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Roberto Agresti, MD

Role: primary

+39 022390 ext. 2168

References

Explore related publications, articles, or registry entries linked to this study.

Elshof LE, Rutgers EJ, Deurloo EE, Loo CE, Wesseling J, Pengel KE, Gilhuijs KG. A practical approach to manage additional lesions at preoperative breast MRI in patients eligible for breast conserving therapy: results. Breast Cancer Res Treat. 2010 Dec;124(3):707-15. doi: 10.1007/s10549-010-1064-z. Epub 2010 Jul 22.

Reference Type BACKGROUND
PMID: 20652399 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

15/13

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.